This article is more than 5 years old. Information may no longer be current.

VIDEO: Hydrus looks to be next MIGS device in US market

ByDave Van Meter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Dave Van Meter, president and CEO of Ivantis, discusses the Hydrus microstent, which has a “trimodal” mechanism of action to lower IOP in patients with glaucoma.